Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition

Oral squamous cell carcinoma (OSCC) is a common human tumor, that originates from buccal mucosa and the tongue, associated with a high mortality rate. Currently, the treatment for OSCC involves surgery, chemotherapy and radiotherapy; however, survival outcomes for OSCC patients remain poor. For this...

Full description

Bibliographic Details
Main Authors: Rossella Basilotta, Marika Lanza, Alessia Filippone, Giovanna Casili, Deborah Mannino, Federica De Gaetano, Giulia Chisari, Lorenzo Colarossi, Gianmarco Motta, Michela Campolo, Salvatore Cuzzocrea, Irene Paterniti, Emanuela Esposito
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2777
_version_ 1797624243234537472
author Rossella Basilotta
Marika Lanza
Alessia Filippone
Giovanna Casili
Deborah Mannino
Federica De Gaetano
Giulia Chisari
Lorenzo Colarossi
Gianmarco Motta
Michela Campolo
Salvatore Cuzzocrea
Irene Paterniti
Emanuela Esposito
author_facet Rossella Basilotta
Marika Lanza
Alessia Filippone
Giovanna Casili
Deborah Mannino
Federica De Gaetano
Giulia Chisari
Lorenzo Colarossi
Gianmarco Motta
Michela Campolo
Salvatore Cuzzocrea
Irene Paterniti
Emanuela Esposito
author_sort Rossella Basilotta
collection DOAJ
description Oral squamous cell carcinoma (OSCC) is a common human tumor, that originates from buccal mucosa and the tongue, associated with a high mortality rate. Currently, the treatment for OSCC involves surgery, chemotherapy and radiotherapy; however, survival outcomes for OSCC patients remain poor. For this reason, it is necessary to investigate new therapeutic strategies to counteract the progression of OSCC. In this study, we aimed to evaluate the role of dimethyl fumarate (DMF) in modulation of OSCC progression, both in vitro and in an in vivo orthotopic xenograft model. In vitro results revealed that DMF was able to reduce the expression of anti-apoptotic factors as BCL-2 and increased the expression of pro-apoptotic factors as Bax, Caspase-3 and BID. DMF appears to be involved in the modulation of oxidative stress mediators, such as MnSOD and HO-1. Furthermore, DMF showed to reduce the migratory ability of tumor cells and to modulate the expression of markers of epithelial-mesenchymal transition (EMT), as N-cadherin and E-cadherin. The in vivo study confirmed the data obtained in vitro significantly decreasing tumor mass and also reducing oxidative stress and apoptosis. Therefore, based on these results, the use of DMF could be considered a promising strategy to counteract oral cancer progression.
first_indexed 2024-03-11T09:40:08Z
format Article
id doaj.art-aa0c09cc009a49b292f0219ad1084e4b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:40:08Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-aa0c09cc009a49b292f0219ad1084e4b2023-11-16T17:02:18ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01243277710.3390/ijms24032777Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal TransitionRossella Basilotta0Marika Lanza1Alessia Filippone2Giovanna Casili3Deborah Mannino4Federica De Gaetano5Giulia Chisari6Lorenzo Colarossi7Gianmarco Motta8Michela Campolo9Salvatore Cuzzocrea10Irene Paterniti11Emanuela Esposito12Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyIstituto Oncologico del Mediterraneo, Via Penninazzo 7, 95029 Viagrande, ItalyIstituto Oncologico del Mediterraneo, Via Penninazzo 7, 95029 Viagrande, ItalyIstituto Oncologico del Mediterraneo, Via Penninazzo 7, 95029 Viagrande, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, 98166 Messina, ItalyOral squamous cell carcinoma (OSCC) is a common human tumor, that originates from buccal mucosa and the tongue, associated with a high mortality rate. Currently, the treatment for OSCC involves surgery, chemotherapy and radiotherapy; however, survival outcomes for OSCC patients remain poor. For this reason, it is necessary to investigate new therapeutic strategies to counteract the progression of OSCC. In this study, we aimed to evaluate the role of dimethyl fumarate (DMF) in modulation of OSCC progression, both in vitro and in an in vivo orthotopic xenograft model. In vitro results revealed that DMF was able to reduce the expression of anti-apoptotic factors as BCL-2 and increased the expression of pro-apoptotic factors as Bax, Caspase-3 and BID. DMF appears to be involved in the modulation of oxidative stress mediators, such as MnSOD and HO-1. Furthermore, DMF showed to reduce the migratory ability of tumor cells and to modulate the expression of markers of epithelial-mesenchymal transition (EMT), as N-cadherin and E-cadherin. The in vivo study confirmed the data obtained in vitro significantly decreasing tumor mass and also reducing oxidative stress and apoptosis. Therefore, based on these results, the use of DMF could be considered a promising strategy to counteract oral cancer progression.https://www.mdpi.com/1422-0067/24/3/2777OSCCDMFoncologyoxidative stressapoptosisEMT
spellingShingle Rossella Basilotta
Marika Lanza
Alessia Filippone
Giovanna Casili
Deborah Mannino
Federica De Gaetano
Giulia Chisari
Lorenzo Colarossi
Gianmarco Motta
Michela Campolo
Salvatore Cuzzocrea
Irene Paterniti
Emanuela Esposito
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
International Journal of Molecular Sciences
OSCC
DMF
oncology
oxidative stress
apoptosis
EMT
title Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
title_full Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
title_fullStr Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
title_full_unstemmed Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
title_short Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
title_sort therapeutic potential of dimethyl fumarate in counteract oral squamous cell carcinoma progression by modulating apoptosis oxidative stress and epithelial mesenchymal transition
topic OSCC
DMF
oncology
oxidative stress
apoptosis
EMT
url https://www.mdpi.com/1422-0067/24/3/2777
work_keys_str_mv AT rossellabasilotta therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT marikalanza therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT alessiafilippone therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT giovannacasili therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT deborahmannino therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT federicadegaetano therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT giuliachisari therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT lorenzocolarossi therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT gianmarcomotta therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT michelacampolo therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT salvatorecuzzocrea therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT irenepaterniti therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition
AT emanuelaesposito therapeuticpotentialofdimethylfumarateincounteractoralsquamouscellcarcinomaprogressionbymodulatingapoptosisoxidativestressandepithelialmesenchymaltransition